Implitapide racemate is primarily utilized in the field of medical research, particularly in the study of lipid metabolism and related disorders. It serves as a potent inhibitor of microsomal triglyceride transfer protein (MTP), making it a valuable tool for investigating conditions such as hyperlipidemia and atherosclerosis. Researchers employ Implitapide racemate to better understand the mechanisms underlying lipid absorption and transport, which can lead to the development of novel therapeutic strategies for managing cardiovascular diseases. Additionally, its role in reducing plasma cholesterol and triglyceride levels has been explored in preclinical studies, highlighting its potential as a candidate for lipid-lowering therapies. However, its use is currently limited to experimental settings, as further studies are required to assess its safety and efficacy in clinical applications.